Morocco DMP Pharmaceutical Registration Process

DMP: The Regulator

The Direction du Médicament et de la Pharmacie (DMP) is the Moroccan pharmaceutical regulatory authority, operating under the Ministry of Health and Social Protection. DMP is responsible for ensuring the quality, safety, and efficacy of medicines, as well as regulating pharmacy practice.

DMP's core functions:

• Product registration and marketing authorization (Autorisation de Mise sur le Marché - AMM)
• Inspecting manufacturing facilities (GMP audits)
• Issuing import and export permits
• Pharmacovigilance and post-market surveillance
• Clinical trial authorization
• Pricing approval and regulation
• Licensing of pharmacies and drug outlets

DMP is headquartered in Rabat, with a partially digitized submission system. French is the working language—all submissions must be in French. The regulatory framework is closely aligned with European standards, and DMP has cooperative agreements with ANSM (France) and other European regulators.

Registration Pathways & Product Categories

DMP offers multiple registration pathways aligned with European standards.

Pathway 1: Full Registration (New Chemical Entities / NCEs)

Full clinical trial data required. Timeline: 12-18 months. Morocco is a significant market for innovative products.

Pathway 2: Abridged Registration (Generic Products)

Requires bioequivalence data from recognized centers. This is the most common pathway. Timeline: 8-12 months.

Pathway 3: Reference Country Recognition (Fast-Track)

Products already registered in France (ANSM), EMA, US FDA, Switzerland, Canada, or Japan qualify for accelerated review. This is the most efficient pathway. Timeline: 4-7 months.

Pathway 4: WHO PQ Recognition

Products with WHO Prequalification receive priority review. Timeline: 5-8 months.

Pathway 5: Locally Manufactured Products

Products manufactured in Morocco receive priority processing (4-6 months) and government procurement preferences.

Prerequisites: What You Need Before Applying

Before submitting to DMP, ensure these items are in place.

• Appoint a Local Agent/Distributor (Exploitant): Foreign manufacturers must appoint a Moroccan company with a valid DMP pharmaceutical license (Exploitant). The agent will hold the registration (Autorisation de Mise sur le Marché).
• Execute a Power of Attorney (Procuration): A notarized document authorizing your local agent. Must be legalized at the Moroccan embassy and translated into French.
• Obtain a Certificate of Pharmaceutical Product (CPP): Issued by your home regulator. Must be in WHO format, less than 2 years old, legalized, and translated into French.
• Prepare Your Dossier in CTD Format: DMP follows CTD format (Modules 1-5). All documents must be in French.
• Bioequivalence Study (for generics): Must be conducted at a recognized center (EMA, ANSM, WHO PQ, or approved international center).
• Product Samples: Required for DMP laboratory testing in Rabat.

Step-by-Step Registration Process

Here's the actual process for registering with DMP. It's one of the more efficient processes in North Africa.

Step 1: Appoint a Local Agent (Exploitant)

Sign an agreement with a Moroccan importer/distributor. Verify their DMP license and their experience with product registration.

Step 2: Execute and Legalize Power of Attorney

Draft Procuration, notarize, legalize at Moroccan embassy, translate to French. This takes 3-4 weeks.

Step 3: Prepare Your French CTD Dossier

Compile CTD dossier (Modules 1-5) in French. DMP accepts electronic submissions via their online portal.

Step 4: Pre-Submission Meeting (Recommended)

Your agent can request a meeting with DMP evaluators. DMP is accessible and professional—recommended for complex products.

Step 5: Online Submission via DMP e-System

Your agent uploads the dossier, pays the application fee (MAD 5,000-15,000/$500-1,500), and receives an acknowledgement.

Step 6: Administrative Screening (3-5 weeks)

DMP checks for completeness, legalization, French translations, and format. Deficiency letters add 3-4 weeks per cycle.

Step 7: Scientific Evaluation (6-10 months)

DMP evaluators review quality, bioequivalence (if applicable), and labeling. Queries issued via e-System. You have 60-90 days to respond.

Step 8: Reference Country Verification (if applicable - 1-2 months)

If using reference country recognition, DMP verifies your existing registration with the reference regulator.

Step 9: Laboratory Testing (1-2 months)

DMP's National Laboratory for Drug Control (LNCM) in Rabat tests product samples. Failure = rejection.

Step 10: GMP Inspection (If Required)

DMP accepts WHO PQ, ANSM (France), EMA, or other SRA inspections. Reference country recognition typically waives inspection.

Step 11: Pricing Approval (1-2 months)

DMP sets the maximum selling price. See pricing section below.

Step 12: DMP Registration Commission Approval (4-6 weeks)

Final approval and certificate issuance (Autorisation de Mise sur le Marché - AMM).

Dossier Requirements: The CTD Format

DMP follows CTD format (Modules 1-5) in French, aligned with European standards.

Module 1: Administrative Information (Morocco-Specific)

• Application letter on manufacturer letterhead (French)
• Cover letter from Moroccan agent (Exploitant - French)
• Power of Attorney (Procuration - legalized, French translation)
• Certificate of Pharmaceutical Product (WHO format, legalized, French, less than 2 years old)
• GMP Certificate (legalized, French)
• Free Sale Certificate (French)
• Manufacturing license (French)
• Labeling and package insert (French - mandatory)
• Reference country registration certificate (if using recognition pathway)
• WHO PQ certificate or SRA approval (if available)

Module 2: Summaries (French)

Module 3: Quality (French)

• Stability data: Morocco has a Mediterranean climate on the coast and varied inland. Zone II/IV data recommended.

Module 4: Nonclinical (NCEs only - French)

Module 5: Clinical/Bioequivalence (French)

Local Agent Requirements: The Exploitant

Morocco's local agent requirements are clear and professional.

What Your Moroccan Agent (Exploitant) Must Have:

• Valid DMP pharmaceutical license (Exploitant)
• Physical warehouse in Casablanca, Rabat, or other major city
• Qualified pharmacist on staff (Pharmacien Responsable)
• Experience with DMP registration and public tender participation
• Cold chain capability (for temperature-sensitive products)
• Quality assurance system (BPF - Bonnes Pratiques de Fabrication for distribution)

Selecting Your Agent:

• Morocco has approximately 30-40 licensed pharmaceutical importers/distributors
• Key players include: Cooper Pharma, Sothema, Laprophan, Pharma 5, and various private distributors
• Many local manufacturers also distribute imported products
• Choose an agent with experience in your therapeutic category and strong relationships with DMP

Bioequivalence Requirements: The European Standard

Morocco has bioequivalence requirements aligned with European standards.

The Basic Requirement:

For generic products, DMP requires a bioequivalence (BE) study demonstrating that your product is equivalent to the reference product (the innovator product registered in Morocco).

Accepted BE Centers:

DMP accepts BE studies from:

• EMA-approved BE centers (European Union)
• ANSM-approved centers (France)
• WHO PQ-approved centers
• US FDA-approved centers
• Health Canada-approved centers
• Moroccan BE centers (limited number, but growing)

Options for BE Studies:

1. Submit existing BE study from a recognized European/North American center: Most common and cost-effective. DMP typically accepts.
2. Conduct BE study at a Moroccan center: Cost: $30,000-70,000. Timeline: 3-6 months. Only needed if no existing study.
3. Apply for a biowaiver: For BCS Class I and III drugs. Timeline: 2-4 months.

Pricing Regulations: The Reference Pricing System

Morocco has a structured pricing system based on international reference pricing.

How Pricing Works:

1. After scientific approval, your agent submits a pricing application to DMP.
2. You propose a Maximum Selling Price (Prix de Vente au Public - PVP).
3. DMP reviews your proposal against:
   • Reference country prices: France, Spain, Portugal, Belgium, Switzerland (primary references)
   • Prices in other North African countries (secondary references)
   • Therapeutic reference pricing (prices of similar products in Morocco)
4. DMP approves a PVP.
5. Prices are typically 40-60% of European reference prices.

Key Pricing Realities:

• Morocco has moderate prices—higher than Algeria and Egypt, lower than Europe and GCC.
• Generics must be priced 20-30% below originators.
• Prices are fixed but can be reviewed annually.
• Public tenders negotiate discounts below the PVP.

GMP Compliance & Facility Inspections

DMP's GMP requirements are aligned with EU GMP standards (influenced by French ANSM).

GMP Evidence DMP Accepts:

• EU GMP certificate (highest acceptance - waives inspection)
• ANSM (France) inspection
• WHO Prequalification
• US FDA inspection
• Other SRA inspections (case-by-case)
• DMP-conducted inspection (rare if other evidence exists)

When Does DMP Conduct Its Own Inspection?

• First-time registration without EU/ANSM/WHO PQ evidence
• Suspected GMP issues
• High-risk products (injectables, biologics)
• Local manufacturing facilities (mandatory for local production)

Inspection Process:

1. DMP notifies your agent (6-8 weeks notice)
2. Fee: MAD 40,000-80,000 ($4,000-8,000) plus travel expenses
3. Inspectors visit for 3-4 days
4. CAPA plan required for findings

Costs, Timelines & Budget Planning

Morocco offers moderate costs and reasonable timelines—good value in North Africa.

Official DMP Fees (Approximate)

• Application fee: MAD 5,000-15,000 ($500-1,500)
• Evaluation fee: MAD 10,000-25,000 ($1,000-2,500)
• Registration certificate (AMM): MAD 5,000-10,000 ($500-1,000)
• Annual retention fee: MAD 2,000-5,000 ($200-500) per product
• Import permit fee: MAD 500-1,000 ($50-100) per shipment

Third-Party Costs

• Regulatory consultant fees: $8,000-18,000 per product
• French translation & certification: $2,000-5,000
• Document legalization: $1,000-2,500
• GMP inspection (if required): $5,000-10,000 plus travel
• Bioequivalence study: $30,000-100,000 if new study needed
• Stability studies: $10,000-25,000
• Local agent fees: $5,000-15,000 annually

Total Estimated Cost Per Product:

• Reference Country Recognition (fastest): $12,000-22,000
• Generic with WHO PQ/EU approval: $15,000-25,000
• Standard generic (well-prepared, existing BE): $20,000-35,000
• Standard generic (new BE study): $50,000-100,000
• Innovative product (NCE): $30,000-60,000+

Timelines:

• Reference Country Recognition: 4-7 months
• WHO PQ Fast-Track: 5-8 months
• Standard generic (well-prepared): 8-12 months
• Standard generic (poor dossier, delays): 12-16 months

Local Manufacturing Incentives

Morocco actively encourages local pharmaceutical manufacturing through various incentives.

Local Manufacturing Advantages:

• Price preference: Locally manufactured products receive 5-10% price advantages in public tenders
• Faster registration: 4-6 months vs. 8-12 months for imports
• Government procurement preference: Local manufacturers are preferred for public tenders
• Tax incentives: Reduced corporate tax rates, duty-free equipment import

Options for Local Manufacturing:

1. Contract manufacturing with Moroccan partner: License your product to a local manufacturer. Fastest route. Lower investment ($500k-2M).
2. Joint venture: Establish a manufacturing JV with a Moroccan company. Moderate investment ($5-15 million).
3. Wholly-owned facility: Build your own plant. High investment ($15-50+ million).

The Tender System: Public Procurement

Morocco's public sector pharmaceutical procurement is managed by the Ministry of Health and the National Agency for Health Procurement (ANAP).

How Tenders Work:

1. Ministry of Health/ANAP issues tender announcements (typically quarterly).
2. Eligible suppliers (registered importers with DMP-registered products) submit bids in French.
3. The Tender Committee evaluates bids based on:
   • Price (40-50% weight) - Competitive pricing required
   • Product quality (30-40% weight) - EU/WHO PQ strongly preferred
   • Local manufacturing status (10-20% weight) - Preference for local production
   • Supplier reliability (10% weight)
4. Winning bids receive contracts for specific quantities.

Public vs. Private Sector:

• Public sector (MOH tenders): 50-60% of market. Lower margins but predictable volume.
• Private sector: 40-50% of market. Higher margins, significant private insurance coverage.

Common Pitfalls & Rejection Reasons

• Documents Not in French: English submissions are rejected
• Invalid or Expired CPP: Less than 2 years old, WHO format required
• Missing Legalization: All foreign documents must be legalized at Moroccan embassy
• Missing French Translations: All documents must have certified French translations
• BE Study Not from Recognized Center: EMA/ANSM/US FDA/WHO PQ preferred
• Incorrect Reference Product for BE: Must use Morocco-registered reference
• Inadequate Stability Data: Appropriate climate zone data required
• GMP Certificate Issues: Expired or not from recognized authority
• No Local Agent Agreement: Valid Exploitant license must be on file
• Product Sample Fails DMP Testing: Immediate rejection

Post-Registration Obligations & Renewal

• Annual Retention Fees: Payable each year via DMP e-System
• Variations: Changes require DMP approval; timeline 2-4 months
• Renewal: Every 5 years, start 6-9 months before expiry
• Pharmacovigilance: Your agent must report adverse events to DMP; PSURs every 2 years
• Price Maintenance: Annual reviews permitted
• Post-Market Surveillance: DMP samples products; failures lead to recalls

North Africa Strategy: Gateway to the Region

Morocco's strategic position extends beyond its borders.

Why Morocco as a North Africa Hub:

• Most accessible regulator in North Africa (vs. Algeria's protectionism, Egypt's bureaucracy)
• European-aligned standards make it easier to meet international requirements
• Trade agreements: Morocco has free trade agreements with the EU, US, and numerous African countries
• Export platform: Products manufactured in Morocco can access African markets via the African Continental Free Trade Area (AfCFTA)
• Stable business environment: Unlike some neighbors, Morocco offers political and economic stability

Regional Comparison:

Conclusion: Your Morocco Entry Strategy

Morocco is the most accessible and strategic pharmaceutical market in North Africa. The regulatory system is professional and European-aligned, the market is substantial, and the private sector offers immediate opportunities without relying solely on government tenders.

Your Morocco registration checklist:

• ✓ Find a Moroccan Exploitant with DMP license and strong market presence
• ✓ Obtain reference country approval (France ANSM, EMA, or US FDA) for fastest pathway
• ✓ Execute and legalize Power of Attorney with French translation
• ✓ Obtain valid CPP (WHO format, less than 2 years old)
• ✓ Prepare CTD dossier in French (professional translation required)
• ✓ Verify BE study is from recognized center (EMA/ANSM/US FDA/WHO PQ)
• ✓ Budget $20,000-35,000 per product ($50-100k with new BE study)
• ✓ Plan for 8-12 months for registration (4-7 months with reference recognition)
• ✓ Develop pricing aligned with European reference countries (expect 40-60% of EU prices)
• ✓ Pursue both private sector distribution and public tender pre-qualification
• ✓ Consider local manufacturing partnerships for volume products
• ✓ Use Morocco as your North African hub for regional expansion
• ✓ Hire a Moroccan regulatory consultant with DMP experience

Is Morocco worth it? Yes—for almost every pharmaceutical exporter targeting North Africa or seeking a gateway to African and European markets. Morocco offers the best balance of market size (38 million), regulatory accessibility, and business environment in the region.

Register in Morocco first. Use the reference country recognition pathway for speed. Build private sector distribution while pursuing public tenders. Then use your Moroccan registration and local partnerships to expand to Algeria, Tunisia, and West Africa. Morocco is the gateway to North Africa—accessible, professional, and profitable.